GlassScriptPhysician profile
Rajasree P Chowdry
NPI 1013234079
$1,545.21
in general payments reported to CMS, 2019-2025
17 companies · $413 in 2025
The $413 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $604 · 2020: $13.30 · 2021: $59.83 · 2022: $26.61 · 2023: $133 · 2024: $295 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $747 · Education: $94.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.36 |
| Education | $94.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $393.78 | 2019-2025 | Opdivo, Krazati |
| Merck Sharp & Dohme LLC | $323.47 | 2019-2025 | Keytruda, Welireg, Reblozyl |
| Caris Mpi, INC. | $135.66 | 2025 | Mi Cancer Seek |
| Tempus Ai, INC | $120.09 | 2024 | |
| Novartis Pharmaceuticals Corporation | $114.19 | 2019-2024 | |
| Lilly USA, LLC | $110.03 | 2019-2025 | |
| Astellas Pharma US INC | $66.41 | 2019-2025 | Xtandi, Xospata |
| Astrazeneca Pharmaceuticals LP | $62.79 | 2019-2024 | Enhertu |
| Janssen Biotech, INC. | $40.31 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.18 | 2020-2023 | |
| Pfizer INC. | $27.03 | 2023-2024 | |
| Abbott Laboratories | $25.17 | 2025 | Epic |
| Exelixis INC. | $22.51 | 2025 | Cabometyx |
| Nevro Corp. | $21.48 | 2023 | Senza |
| Amgen INC. | $20.21 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $18.98 | 2019 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rajasree Chowdry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.